Cell Insight 润色咨询

Cell Insight

出版年份：2021 年文章数：暂无数据 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1240604, encodeId=d62a12406047b, content=这个影响因子是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=636c8290325, createdName=ms2000002035884800, createdTime=Tue Aug 23 22:15:07 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207638, encodeId=b68b120e63805, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86724765960, createdName=wy061460, createdTime=Thu Mar 31 19:44:06 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059222, encodeId=3ca110592223c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;细胞生物学;免疫学<br>经验分享：Cell Insight由中科院院士、武汉大学舒红兵教授担任主编，病毒学国家重点实验室主任、武汉大学蓝柯教授担任执行主编，由来自中国、美国、加拿大、英国、澳大利亚、日本、意大利、比利时、韩国等全球著名学术机构的40余位学者担任编委。<br><br>审稿流程<br><br>Cell Insight 将提供专业且快速的论文审稿流程，论文投稿一周内决定是否送审，对送审稿件在二至四周内返回审稿意见，接受稿件 1 月内在线发表，同时在**公众号加以推送。此外，Cell Insight 还对某些高水平、存在激烈竞争的稿件提供绿色通道快速发表。<br><br>诚邀投稿<br>Cell Insight 将于 2022 年 1 月正式出版第一期，创刊前三年所发表的文章均免除文章出版费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Oct 10 17:34:02 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193768, encodeId=7abf1193e68e2, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=13777777735, createdTime=Tue Feb 15 21:42:43 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132329, encodeId=d9df113232953, content=post-hoc/事后检验是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:53:00 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132330, encodeId=35df11323305a, content=为什么要进行事后检验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:53:00 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-08-23 ms2000002035884800

    这个影响因子是多少

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1240604, encodeId=d62a12406047b, content=这个影响因子是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=636c8290325, createdName=ms2000002035884800, createdTime=Tue Aug 23 22:15:07 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207638, encodeId=b68b120e63805, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86724765960, createdName=wy061460, createdTime=Thu Mar 31 19:44:06 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059222, encodeId=3ca110592223c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;细胞生物学;免疫学<br>经验分享：Cell Insight由中科院院士、武汉大学舒红兵教授担任主编，病毒学国家重点实验室主任、武汉大学蓝柯教授担任执行主编，由来自中国、美国、加拿大、英国、澳大利亚、日本、意大利、比利时、韩国等全球著名学术机构的40余位学者担任编委。<br><br>审稿流程<br><br>Cell Insight 将提供专业且快速的论文审稿流程，论文投稿一周内决定是否送审，对送审稿件在二至四周内返回审稿意见，接受稿件 1 月内在线发表，同时在**公众号加以推送。此外，Cell Insight 还对某些高水平、存在激烈竞争的稿件提供绿色通道快速发表。<br><br>诚邀投稿<br>Cell Insight 将于 2022 年 1 月正式出版第一期，创刊前三年所发表的文章均免除文章出版费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Oct 10 17:34:02 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193768, encodeId=7abf1193e68e2, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=13777777735, createdTime=Tue Feb 15 21:42:43 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132329, encodeId=d9df113232953, content=post-hoc/事后检验是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:53:00 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132330, encodeId=35df11323305a, content=为什么要进行事后检验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:53:00 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-03-31 wy061460

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：期待

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1240604, encodeId=d62a12406047b, content=这个影响因子是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=636c8290325, createdName=ms2000002035884800, createdTime=Tue Aug 23 22:15:07 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207638, encodeId=b68b120e63805, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86724765960, createdName=wy061460, createdTime=Thu Mar 31 19:44:06 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059222, encodeId=3ca110592223c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;细胞生物学;免疫学<br>经验分享：Cell Insight由中科院院士、武汉大学舒红兵教授担任主编，病毒学国家重点实验室主任、武汉大学蓝柯教授担任执行主编，由来自中国、美国、加拿大、英国、澳大利亚、日本、意大利、比利时、韩国等全球著名学术机构的40余位学者担任编委。<br><br>审稿流程<br><br>Cell Insight 将提供专业且快速的论文审稿流程，论文投稿一周内决定是否送审，对送审稿件在二至四周内返回审稿意见，接受稿件 1 月内在线发表，同时在**公众号加以推送。此外，Cell Insight 还对某些高水平、存在激烈竞争的稿件提供绿色通道快速发表。<br><br>诚邀投稿<br>Cell Insight 将于 2022 年 1 月正式出版第一期，创刊前三年所发表的文章均免除文章出版费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Oct 10 17:34:02 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193768, encodeId=7abf1193e68e2, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=13777777735, createdTime=Tue Feb 15 21:42:43 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132329, encodeId=d9df113232953, content=post-hoc/事后检验是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:53:00 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132330, encodeId=35df11323305a, content=为什么要进行事后检验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:53:00 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-10-10 病毒猎手

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：癌症;细胞生物学;免疫学
    经验分享：Cell Insight由中科院院士、武汉大学舒红兵教授担任主编，病毒学国家重点实验室主任、武汉大学蓝柯教授担任执行主编，由来自中国、美国、加拿大、英国、澳大利亚、日本、意大利、比利时、韩国等全球著名学术机构的40余位学者担任编委。

    审稿流程

    Cell Insight 将提供专业且快速的论文审稿流程，论文投稿一周内决定是否送审，对送审稿件在二至四周内返回审稿意见，接受稿件 1 月内在线发表，同时在**公众号加以推送。此外，Cell Insight 还对某些高水平、存在激烈竞争的稿件提供绿色通道快速发表。

    诚邀投稿
    Cell Insight 将于 2022 年 1 月正式出版第一期，创刊前三年所发表的文章均免除文章出版费。

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1240604, encodeId=d62a12406047b, content=这个影响因子是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=636c8290325, createdName=ms2000002035884800, createdTime=Tue Aug 23 22:15:07 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207638, encodeId=b68b120e63805, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86724765960, createdName=wy061460, createdTime=Thu Mar 31 19:44:06 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059222, encodeId=3ca110592223c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;细胞生物学;免疫学<br>经验分享：Cell Insight由中科院院士、武汉大学舒红兵教授担任主编，病毒学国家重点实验室主任、武汉大学蓝柯教授担任执行主编，由来自中国、美国、加拿大、英国、澳大利亚、日本、意大利、比利时、韩国等全球著名学术机构的40余位学者担任编委。<br><br>审稿流程<br><br>Cell Insight 将提供专业且快速的论文审稿流程，论文投稿一周内决定是否送审，对送审稿件在二至四周内返回审稿意见，接受稿件 1 月内在线发表，同时在**公众号加以推送。此外，Cell Insight 还对某些高水平、存在激烈竞争的稿件提供绿色通道快速发表。<br><br>诚邀投稿<br>Cell Insight 将于 2022 年 1 月正式出版第一期，创刊前三年所发表的文章均免除文章出版费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Oct 10 17:34:02 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193768, encodeId=7abf1193e68e2, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=13777777735, createdTime=Tue Feb 15 21:42:43 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132329, encodeId=d9df113232953, content=post-hoc/事后检验是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:53:00 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132330, encodeId=35df11323305a, content=为什么要进行事后检验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:53:00 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-02-15 13777777735

    #期刊推荐#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1240604, encodeId=d62a12406047b, content=这个影响因子是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=636c8290325, createdName=ms2000002035884800, createdTime=Tue Aug 23 22:15:07 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207638, encodeId=b68b120e63805, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86724765960, createdName=wy061460, createdTime=Thu Mar 31 19:44:06 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059222, encodeId=3ca110592223c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;细胞生物学;免疫学<br>经验分享：Cell Insight由中科院院士、武汉大学舒红兵教授担任主编，病毒学国家重点实验室主任、武汉大学蓝柯教授担任执行主编，由来自中国、美国、加拿大、英国、澳大利亚、日本、意大利、比利时、韩国等全球著名学术机构的40余位学者担任编委。<br><br>审稿流程<br><br>Cell Insight 将提供专业且快速的论文审稿流程，论文投稿一周内决定是否送审，对送审稿件在二至四周内返回审稿意见，接受稿件 1 月内在线发表，同时在**公众号加以推送。此外，Cell Insight 还对某些高水平、存在激烈竞争的稿件提供绿色通道快速发表。<br><br>诚邀投稿<br>Cell Insight 将于 2022 年 1 月正式出版第一期，创刊前三年所发表的文章均免除文章出版费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Oct 10 17:34:02 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193768, encodeId=7abf1193e68e2, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=13777777735, createdTime=Tue Feb 15 21:42:43 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132329, encodeId=d9df113232953, content=post-hoc/事后检验是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:53:00 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132330, encodeId=35df11323305a, content=为什么要进行事后检验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:53:00 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    post-hoc/事后检验是什么东西？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1240604, encodeId=d62a12406047b, content=这个影响因子是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=636c8290325, createdName=ms2000002035884800, createdTime=Tue Aug 23 22:15:07 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207638, encodeId=b68b120e63805, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86724765960, createdName=wy061460, createdTime=Thu Mar 31 19:44:06 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059222, encodeId=3ca110592223c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;细胞生物学;免疫学<br>经验分享：Cell Insight由中科院院士、武汉大学舒红兵教授担任主编，病毒学国家重点实验室主任、武汉大学蓝柯教授担任执行主编，由来自中国、美国、加拿大、英国、澳大利亚、日本、意大利、比利时、韩国等全球著名学术机构的40余位学者担任编委。<br><br>审稿流程<br><br>Cell Insight 将提供专业且快速的论文审稿流程，论文投稿一周内决定是否送审，对送审稿件在二至四周内返回审稿意见，接受稿件 1 月内在线发表，同时在**公众号加以推送。此外，Cell Insight 还对某些高水平、存在激烈竞争的稿件提供绿色通道快速发表。<br><br>诚邀投稿<br>Cell Insight 将于 2022 年 1 月正式出版第一期，创刊前三年所发表的文章均免除文章出版费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Oct 10 17:34:02 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193768, encodeId=7abf1193e68e2, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=13777777735, createdTime=Tue Feb 15 21:42:43 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132329, encodeId=d9df113232953, content=post-hoc/事后检验是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:53:00 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1132330, encodeId=35df11323305a, content=为什么要进行事后检验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:53:00 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 MS68862005

    为什么要进行事后检验？

    1

    展开1条回复
共11条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分